Biotechnology Clinical Trials Pharmaceuticals

A Change in Bacteria’s Genetic Code Holds Promise of Longer-Lasting Drugs

By altering the genetic code in bacteria, researchers at The University of Texas at Austin have demonstrated a method to make therapeutic proteins more stable, an advance that would improve the drugs' effectiveness and convenience, leading to smaller and less frequent doses of medicine, lower health care costs and fewer side effects for patients with cancer and other diseases. The results were published today in the journal Nature Biotechnology. [June 4, 2018]
Cancer Discovery

Study Suggests Way to Attack Deadly, Untreatable Nerve Tumors

Photo caption: This microscopic image uses immunostaining to highlight the presence of TAZ/YAP (shown in green) in human malignant peripheral nerve sheath tumors that grew from Schwann cells. The job of Schwann cells is to form the protective nerve sheath. The cell nuclei are shown in blue. The image is from a study by scientists at Cincinnati Children’s published by the journal Cancer Cell. Genomic profiling of mostly untreatable and